# EXCALIBUR (NCT04915508)

> Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04915508
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Jonsson Comprehensive Cancer Center
- Conditions: Prostate Adenocarcinoma; Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8; Stage IIIC Prostate Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8
- Interventions: Hormone Therapy; Stereotactic Body Radiation Therapy
- Enrollment: 165
- Primary outcome: Change of Expanded Prostate Cancer Index (EPIC) score for the gastrointestinal domain
- Primary outcome: Change of Expanded Prostate Cancer Index (EPIC) score for the genitourinary domain

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 59
- Podcasts: 25
- X threads: 17
- X videos: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=excalibur-nct04915508

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04915508", "email": "<work email>"}; the inbox owner confirms by the emailed link.